Colorado Patent of the Month – January 2024
Xiant Technologies, Inc. (XTi) – experts in biotechnology – has unveiled a groundbreaking method for hormone regulation in mammals, leveraging the power of photon modulation. This revolutionary system involves a sophisticated interplay of components, orchestrated to produce a photon signal directed toward the mammal, with the capacity to influence hormone levels and behavioral patterns.
At the core of this invention lies the deployment of photon emitters and modulation controllers, working in tandem to create a photon signal composed of two distinct components. The first, characterized by a repetitive modulated photon pulse group with varying durations, intensities, and a specific wavelength color; and the second, a separate modulated photon pulse group with its unique set of parameters, including a distinctive far red wavelength color. Importantly, these components operate simultaneously, creating a signal that holds the potential to regulate hormone levels in mammals.
The versatility of this method is exemplified by its ability to both increase and decrease hormone production in mammals. Whether there’s a need for a hormonal boost or a controlled reduction, XTi’ system offers a spectrum of possibilities. The regulation spans a wide array of hormones, from those associated with the hypothalamus to pituitary hormones, providing a comprehensive approach to mammalian endocrine control.
The wavelengths chosen for photon pulses play a pivotal role in the effectiveness of this method. The carefully selected range, including near red and far red wavelengths, ensures optimal interaction with the mammal’s photoreceptors, facilitating the desired hormonal responses.
The invention incorporates a master logic controller that oversees and adjusts the parameters of photon pulses, enhancing the precision and adaptability of the system. Monitoring power consumption and environmental or physiological conditions associated with the mammal adds an extra layer of sophistication, allowing real-time adjustments for maximum efficacy.
XTi has not only introduced a method but a paradigm shift in hormone regulation, where photon modulation takes center stage in shaping the well-being and behavior of mammals. This innovation transcends traditional approaches, offering a glimpse into the future of personalized hormonal control and its wide-ranging applications.
Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.
Who We Are:
Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.
Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.
